Cocrystal Pharma, Inc.

Healthcare · Biotechnology · United States

Last price 0.98 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 18.88M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment fo...